Biochemical and clinical effects of continuous positive airway pressure combined with sildenafil on inflammatory and hemodynamic profiles in obese asthma patients with pulmonary arterial hypertension
Abstract
Background: Obesity-associated asthma complicated by pulmonary arterial hypertension (PAH) involves multifactorial biochemical dysregulation, including endothelial dysfunction, oxidative stress, and chronic inflammation. This study aimed to evaluate the combined biochemical and clinical effects of continuous positive airway pressure (CPAP) and sildenafil on pulmonary function, inflammatory biomarkers, and hemodynamic parameters in obese asthma patients with PAH.
Methods: A total of 134 patients (BMI >30 kg/m2, FEV1 30 mmHg) were enrolled and divided into a treatment group (n = 63, CPAP + sildenafil) and a control group (n = 71, sildenafil alone). Pulmonary and hemodynamic indices (PaÜ2, FiÜ2, PASP, OI, and PaO2/FiO2), lung function parameters (FEV1 , PEF), and asthma control test (ACT) scores were assessed at baseline and follow-up (6 and 12 months). Serum interleukin-6 (IL-6), tumor necrosis factor-a (TNF-α), and fractional exhaled nitric oxide (FeNO) were quantified to evaluate biochemical inflammation. Correlation analysis was performed between biomarker changes and ACT improvements.
Results: The CPAP + sildenafil group showed significantly higher post-treatment PaÜ2 levels, lower PASP and FiÜ2 values, improved OI, and greater increases in PaO2/FiO2 and FEV1 percentages compared with the control group (P < 0.001). Biochemical assays revealed substantial reductions in serum IL-6 and TNF-α levels, as well as FeNO concentrations, in the combination group. Post-treatment…
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.